Biotech Innovation Gallery (BIG) Accelerator Startups
2022 BIG Startups
Eunicera is developing novel therapeutics to treat and cure advanced drug-resistant recurrent prostate cancer.
| Allen Gao Co-founder |
 |
 |
Rapid, reliable mental health triage and clinical consultation with research-grade asynchronous telepsychiatry, built for health systems, schools, and clinical research organizations (CROs).
| Peter Yellowlees Co-founder |
 |
|
|
KiBio has developed new small molecule inhibitors of galectin-1 for malignant peripheral nerve sheath tumor (MPNST) and prostate cancer.
| Tsung Shih Founder |
|
|
VGN Bio is developing viral protein-derived peptide drugs that selectively kill cancer cells, while keeping normal cells intact. The developed peptide complexes with the MYC gene leading to cancer cell death.
| Michiko Shimoda Co-founder |
|
|
Histolix represents the next generation of rapid slide-free tissue imaging and decision-support tools that address
critical needs in cancer care and medical diagnostics. The technology provides real-time results at half the cost of conventional approaches.
| Rob Royea CEO |
|
|
|
Matrubials is developing therapeutics from mammalian milk to combat severe bacterial infections and modern
diseases with an initial focus on women’s health.
| Ishita Shah Co-founder |
|
|
|
Machine Intelligence Learning Optimizer is a turnkey health software tool that provides a fully automated ML/AIsolution to improve patient care and save lives.
| Hooman Rashidi Co-founder |
|
|
Molecular Matrix is developing an innovative platform technology for tissue regeneration applications. Osteopoietic Systems™ is their first clinical solution to the need for value-driven and safe bone regeneration products.
| Charles Lee Founder |
|
|
|
Mirnova Therapeutics is developing small molecules and microRNA drugs for treatment of traumatic brain injury and other neurological disorders.
| DaZhi Liu Founder |
|
|
|
Previously Participating Startups
InVixa is developing lung-targeted therapies to treat Covid 19, using inhaled statins to allow for a more targeted, effective treatment with lower doses and side effects.
| Amir Zeki Founder |
|
Botanical Solutions has a proprietary R&D platform for sustainable and improved production of consistent, high quality Advanced Botanical Materials (ABM).
| Gaston Salinas Co-founder |
|
|
|
NeoPOSE is revolutionizing the way we diagnose Critical Congenital Heart disease in newborns, enabling doctors to catch these conditions sooner and save lives.
| Heather Siefkes Founder |
|
Innate Biology is the world’s first biotech company dedicated to the research and development of fasting mimetics designed from human research to extend lifespan and improve cellular health.
| Chris Rhodes Co-founder |
|
|
Protein Architects are developing solutions for the detection, protection, prediction, and adaptive therapeutics against zoonotic threats.
| Rick Davis Co-founder |
|
|
|
Ravata Solutions has developed an innovative diagnostic tool to measure human embryo quality for use in In-Vitro Fertilization (IVF).
| Gurkern Sufi Founder |
|
|
|
Seven Biosciences is a GPCR targeted drug discovery company which engineers and uses cutting-edge fluorecent biosensor technology.
| Grace Mizuno CEO & Co-founder |
|
|
|
Storx Technologies develops non-invasive fetal oximetry.
| Soheil Ghiasi Founder |
|
|
|
Tendel Therapies is developing first-in-class genetic adjuvants to direct novel, potent, and durable immune responses with a command line level of control.
| Corey Miller CEO |
|
|
Tesio Pharmaceuticals is developing best-in-class therapeutics to treat and prevent osteoarthritis.
| Dominik Haudenschild Founder |
|
|
AMCYT is developing the first automated rapid onsite evaluation (ROSE) device.
| Alejandro Mendoza Founder |
|
|
|
ARIZ Precision Medicine targets epigenetic changes that occur early in cancerization with siRNA-based therapeutics delivered directly to tumor cells.
| Brad Niles Co-founder |
|
|
Astrid Pharma is specialized in the next-generation nanocarrier drug delivery systems with their non- infectious HEVNP encapsulation platform.
| Chun-Chieh Chen Founder |
|
BCD Bioscience catalogs the broadly untapped world of natural carbohydrate structures to efficiently create and commercialize novel prebiotics, synbiotics and immuno-modulatory therapies for human and animal health.
| Matt Amicucci Co-founder |
|
|
Buto Corp specializes in developing novel therapeutics for metabolic diseases.
| Gino Cortopassi Founder |
|
|
Certus Critical Care has designed the EVAC System as a next-generation endovascular technology for precision control of hemodynamics in patients with stroke, cardiac arrest, or uncontrolled hemorrhage.
| Austin Johnson Co-Founder |
|
|
Cognivive is solving neuro-rehabilitation’s most intractable problem – the absence of effective, motivating treatments for patients to use at home. We translate unique science into digital medicines delivered via Virtual Reality.
| Tony Simon Founder |
|
|
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature’s most ancient therapies, psychedelics.
| Nicholas Haft CEO |
|
|
Digestiva is a company focused on improving the nutritional efficiency of protein utilization.
| Joel Cherry Co-founder |
|
|
EffectorBio is developing novel peptide therapeutics to treat pulmonary fibrosis which is currently a large unmet need.
| Reen Wu Founder |
|
|
EicOsis is a clinical stage pharmaceutical company developing a first-in-class once daily oral therapeutic for neuropathic and inflammatory pain, targeting a novel enzyme, soluble epoxide hydrolase, to alleviate pain without the side effects such as sedation, addiction, or GI side effects found in current analgesics.
| Glenn Croston COO |
|
|
Furanica is developing drug therapeutics to treat various metabolic syndromes, including severe hypertriglyceridemia and nonalcoholic fatty liver disease.
| Fei Chang Co-Founder |
|
HistoliX represents the next generation of rapid slide-free tissue imaging and decision-support tools that address critical needs in cancer care and medical diagnostics.
| Gary Gerttula CEO |
|
|
InStatin is developing lung-targeted therapies to treat chronic respiratory diseases, starting with severe asthma.
| Amir Zeki Co-Founder |
|
|
Ixchel Pharma is developing small-molecule drugs to treat mitochondrial diseases.
| Gino Cortopassi Founder |
|
|
Mara BioSystems is developing autism-oriented specialty clinical diagnostic tools to identify prospective mothers, prior to conception, who have a high risk of producing ASD children.
| James Woody CEO |
|
|
|
Matrubials is developing therapeutics from mammalian milk to combat severe bacterial infections and modern diseases with an initial focus on women’s health.
| Ishita Shah Co-founder |
|
 |
Mirnova Therapeutics leverages cancer elements (oncogenes/kinases, tumor suppressors) to develop small molecules and microRNA drugs for treatment of neurological disorders, such as stroke, traumatic brain injury, as well as SARS-CoV-2 associated brain injury.
| DaZhi Liu Founder |
|
|
Pandomedx is developing therapeutics to treat and cure advanced prostate cancer.
| Allen Gao Co-Founder |
|
Paramag Biosciences is developing a novel small molecule platform to treat and diagnose disorders associated with protein misfolding, including Alzheimer’s Disease, Huntington’s Disease and others.
| John Voss Founder |
|
|
Sanguinity Diagnostics has developed a unique biomarker platform to accurately identify patients that will best respond to a given drug.
| Boryana Stamova Co-Founder |
|
|
 |
Sierra Biopharma is developing therapeutics that selectively neutralize, remove, and destroy immune components that lead to the autoimmune disease myasthenia gravis.
| Vu Trinh Co-Founder |
|
|
|
Syncanica is developing synthetic cannabinoids as a more effective, legal, safer, and less expensive alternative to cannabis-derived CBD for consumer and therapeutic uses.
| Larry Shaeffer CEO |
|
|
Theranostec is an early stage start-up developing precision medicines for cancer-specific drug delivery and improved cancer patient care.
| Aaron Lindstrom Co-founder |
|
|
|
VasoBio is developing vascular grafts and other blood contacting devices for surgical disease treatment.
| Aijun Wang Founder |
|
|
Verndari is developing a novel vaccine delivery technology, VaxiPatch, a proprietary painless skin patch, with various virus-like particle vaccines including SARS-COV2, Hep B, HPV, and Flu vaccines, to achieve simpler delivery and high efficacy.
| Daniel R. Henderson CEO |
|
|
ViVita Technologies has developed a process to make human tissue and organ replacements to overcome the donor organ and tissue shortage.
| Maelene Wong Co-Founder and CEO |
|
|